Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Rapid Micro Biosystems has announced the commercial launch of its proprietary platform, Growth Direct System, for rapidly detecting microbial contaminants in the manufacture of pharmaceutical, biotechnology and personal care products.
Subscribe to our email newsletter
The Growth Direct System is claimed to be the first and only automated system for rapid microbial detection that addresses all of the manufacturers’s key testing applications and fits with current regulatory practices, a critical accelerator for adoption. The system is now commercially available for shipment in North America and will be available for delivery to customers in Europe in the second half of 2008.
Steve Delity, president and CEO of Rapid Micro, said: “Our system is unique because it can address the full market of 350 million tests, encompassing the entire spectrum of applications. Adoption of the Growth Direct System will drive productivity for our customers and strong recurring revenue for the company.”